Who are Y-Prime's investors?

Y-Prime's investors include Flexpoint Ford, Gray Ventures, Ballast Point Ventures.

How much funding has Y-Prime raised?

Y-Prime has disclosed $6.6M raised across 3 rounds.

Where is Y-Prime headquartered?

Y-Prime is headquartered in Malvern, US.

Y-Prime

Malvern, US · 3 known investors

YPrime provides eClinical technology—including eCOA, IRT, eConsent, and participant-engagement tools—along with consulting and 24/7 support for running clinical trials. It serves pharmaceutical companies, biotechs, and CROs conducting global studies across therapeutic areas such as oncology, rare disease, CNS, and vaccines.

BiotechDigital HealthSaaS

Founders & leadership

Jaime COOKExecutive

Shawn BLACKBURNExecutive

Matthew RiceNamed on SEC filing

Richard GastineauNamed on SEC filing

Elizabeth TallettNamed on SEC filing

James PuseyNamed on SEC filing

Paul BlakeNamed on SEC filing

Shawn BlackburnNamed on SEC filing

Jaime CookNamed on SEC filing

Board

Matthew RICE inBoard directorPartner at Ballast Point Ventures

Elizabeth TALLETTBoard director

Richard GASTINEAUBoard director

Investors · 3

Flexpoint FordChicago

Gray VenturesAtlanta

Ballast Point VenturesreportedTampa · $5M – $15Mvia Sean Barkman · board

Reported raises · per SEC filings

Form D private placements

$6.6M disclosed across 3 rounds · 2014–2017

▶$2.1MraisedNov 2017 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

JAMES WALKERDirector
MARK MAIETTAExecutive Officer
SEAN BARKMANDirector
MATTHEW RICEDirector
SHAWN BLACKBURNExecutive Officer, Director
JAIME COOKExecutive Officer
TRAVIS MILKSDirector

Offering amount: $2.1M
Amount sold: $2.1M
First sale: Oct 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedMar 2016 · 2 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Elizabeth TALLETTDirector
Richard GASTINEAUDirector
Jaime COOKExecutive Officer, Director
Matthew RICEDirector
Paul BLAKEDirector
Shawn BLACKBURNExecutive Officer, Director
James WALKERDirector

Offering amount: $2M
Amount sold: $2M
First sale: Feb 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.5MraisedOct 2014 · 2 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Matthew RiceDirector
Richard GastineauDirector
Elizabeth TallettDirector
James PuseyDirector
Paul BlakeDirector
Shawn BlackburnExecutive Officer, Director
Jaime CookExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $2.5M
Sales commissions: $50K
Placement agents: Centerstone Partners, LLC
First sale: Sep 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Y-Prime do?: YPrime provides eClinical technology—including eCOA, IRT, eConsent, and participant-engagement tools—along with consulting and 24/7 support for running clinical trials. It serves pharmaceutical companies, biotechs, and CROs conducting global studies across therapeutic areas such as oncology, rare disease, CNS, and vaccines.
Who are Y-Prime's investors?: Y-Prime's investors include Flexpoint Ford, Gray Ventures, Ballast Point Ventures.
How much funding has Y-Prime raised?: Y-Prime has disclosed $6.6M raised across 3 rounds.
Where is Y-Prime headquartered?: Y-Prime is headquartered in Malvern, US.